Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2015 1
2017 3
2018 1
2021 2
2023 5
2024 4
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the International Vitiligo Task Force Part 1: towards a new management algorithm.
van Geel N, Speeckaert R, Taïeb A, Ezzedine K, Lim HW, Pandya AG, Passeron T, Wolkerstorfer A, Abdallah M, Alomar A, Bae JM, Bekkenk M, Benzekri L, Böhm M, Eleftheriadou V, Esmat S, Ghia D, Goh BK, Grimes P, Gupta S, Hamzavi IH, Harris JE, Oh SH, Huggins R, Katayama I, Lan E, Lee AY, Leone G, Le Poole C, Lui H, Maquignon N, Meurant JM, Monteiro P, Oiso N, Parsad D, Pliszewski G, Raboobee N, Rodrigues M, Rosmarin D, Suzuki T, Tanemura A, Thng S, Xiang F, Zhou Y, Picardo M, Seneschal J. van Geel N, et al. Among authors: rodrigues m. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2173-2184. doi: 10.1111/jdv.19451. Epub 2023 Sep 25. J Eur Acad Dermatol Venereol. 2023. PMID: 37746876
BACKGROUND: The treatment of vitiligo can be challenging and depends on several factors such as the subtype, disease activity, vitiligo extent, and treatment goals. Vitiligo usually requires a long-term approach. To improve the management of vitiligo w …
BACKGROUND: The treatment of vitiligo can be challenging and depends on several factors such as the subtype, disease activity, vit …
Worldwide expert recommendations for the diagnosis and management of vitiligo: Position statement from the international Vitiligo Task Force-Part 2: Specific treatment recommendations.
Seneschal J, Speeckaert R, Taïeb A, Wolkerstorfer A, Passeron T, Pandya AG, Lim HW, Ezzedine K, Zhou Y, Xiang F, Thng S, Tanemura A, Suzuki T, Rosmarin D, Rodrigues M, Raboobee N, Pliszewski G, Parsad D, Oiso N, Monteiro P, Meurant JM, Maquignon N, Lui H, Le Poole C, Leone G, Lee AY, Lan E, Katayama I, Huggins R, Oh SH, Harris JE, Hamzavi IH, Gupta S, Grimes P, Goh BK, Ghia D, Esmat S, Eleftheriadou V, Böhm M, Benzekri L, Bekkenk M, Bae JM, Alomar A, Abdallah M, Picardo M, van Geel N. Seneschal J, et al. Among authors: rodrigues m. J Eur Acad Dermatol Venereol. 2023 Nov;37(11):2185-2195. doi: 10.1111/jdv.19450. Epub 2023 Sep 15. J Eur Acad Dermatol Venereol. 2023. PMID: 37715487
BACKGROUND: The treatment of vitiligo can be challenging. Up-to-date agreed consensus recommendations on the use of topical and systemic therapies to facilitate the clinical management of vitiligo are currently lacking. ...CONCLUSIONS: This international consensus s …
BACKGROUND: The treatment of vitiligo can be challenging. Up-to-date agreed consensus recommendations on the use of topical and syste …
New discoveries in the pathogenesis and classification of vitiligo.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group. Rodrigues M, et al. J Am Acad Dermatol. 2017 Jul;77(1):1-13. doi: 10.1016/j.jaad.2016.10.048. J Am Acad Dermatol. 2017. PMID: 28619550 Review.
Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy depigmentation. ...Presentation patterns of vitiligo vary, and recognition of these patterns provides both diagnostic and prognostic cl …
Vitiligo is a common autoimmune disease that progressively destroys melanocytes in the skin, resulting in the appearance of patchy de …
Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients.
Renert-Yuval Y, Ezzedine K, Grimes P, Rosmarin D, Eichenfield LF, Castelo-Soccio L, Huang V, Desai SR, Walsh S, Silverberg JI, Paller AS, Rodrigues M, Weingarten M, Narla S, Gardner J, Siegel M, Ibad S, Silverberg NB. Renert-Yuval Y, et al. Among authors: rodrigues m. JAMA Dermatol. 2024 Apr 1;160(4):453-461. doi: 10.1001/jamadermatol.2024.0021. JAMA Dermatol. 2024. PMID: 38477910 Review.
IMPORTANCE: Evidence-based recommendations for the treatment of vitiligo in pediatric, adolescent, and young adult patients in the US are needed. OBJECTIVE: To develop evidence- and consensus-based expert recommendations on the diagnosis and treatment of vitiligo in …
IMPORTANCE: Evidence-based recommendations for the treatment of vitiligo in pediatric, adolescent, and young adult patients in the US …
Assessment of vitiligo in clinical practice: a cross-sectional survey among experts.
Duponselle J, Jukema MR, Wolkerstorfer A, Ezzedine K, Hamzavi I, Seneschal J, Eleftheriadou V, Pandya AG, Garg A, Ganesan A, Goh BK, Parsad D, Ghia D, Rosmarin D, Leone G, Lim HW, Ju HJ, Bae JM, Ferguson J, Benzekri L, Abdallah M, Böhm M, Picardo M, Rashighi M, Ramam M, Rodrigues M, Raboobee N, Spuls P, Esmat S, Thng STG, Passeron T, Huang V, Speeckaert R, van Geel N. Duponselle J, et al. Among authors: rodrigues m. J Dermatolog Treat. 2025 Dec;36(1):2555984. doi: 10.1080/09546634.2025.2555984. Epub 2025 Oct 10. J Dermatolog Treat. 2025. PMID: 41070632 Free article.
METHODS: A cross-sectional survey was conducted among 31 vitiligo experts from six continents. The survey consisted of 28 predefined outcomes and characteristics. ...The most frequently chosen outcomes included vitiligo evolution, tolerability of treatment/adverse e …
METHODS: A cross-sectional survey was conducted among 31 vitiligo experts from six continents. The survey consisted of 28 predefined …
Current and emerging treatments for vitiligo.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE; Vitiligo Working Group. Rodrigues M, et al. J Am Acad Dermatol. 2017 Jul;77(1):17-29. doi: 10.1016/j.jaad.2016.11.010. J Am Acad Dermatol. 2017. PMID: 28619557 Review.
Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available for vitiligo. ...
Clinicians should be aware that vitiligo is not merely a cosmetic disease and that there are safe and effective treatments available …
Dermoscopy in vitiligo, diagnostic clues and markers of disease activity: a review of the literature.
Yang Y, Morriss S, Rodrigues M. Yang Y, et al. Among authors: rodrigues m. Clin Exp Dermatol. 2024 Aug 22;49(9):969-975. doi: 10.1093/ced/llad365. Clin Exp Dermatol. 2024. PMID: 38195089 Review.
Vitiligo can be diagnosed on dermoscopy by the presence of white structureless areas signifying hypopigmentation with a typical glowing appearance. ...In total, 15 studies were reviewed to determine the dermoscopic signs of the three main stages of disease activity: active …
Vitiligo can be diagnosed on dermoscopy by the presence of white structureless areas signifying hypopigmentation with a typical glowi …
Concurrent management of vitiligo and acquired disorders of hyperpigmentation: a comprehensive literature review and current practice gaps.
Lane BN, Hamzavi IH, Lim HW, Rodrigues M, Elbuluk N, Mohammad TF. Lane BN, et al. Among authors: rodrigues m. Int J Dermatol. 2025 Mar;64(3):485-489. doi: 10.1111/ijd.17631. Epub 2025 Jan 16. Int J Dermatol. 2025. PMID: 39817312 Review.
Few studies discuss the co-management of vitiligo and acquired hyperpigmentation disorders (AHD) such as melasma, erythema dyschromicum perstans, post-inflammatory hyperpigmentation, drug-induced hyperpigmentation, and lichen planus pigmentosus. ...Platelet-rich plasma (PR …
Few studies discuss the co-management of vitiligo and acquired hyperpigmentation disorders (AHD) such as melasma, erythema dyschromic …
Definition of Severity and Relapse for Vitiligo: An International Consensus Statement.
Eleftheriadou V, Desai S, Bae JM, Taylor S, Meurant JM, Abdallah M, Ju HJ, Benzekri L, Wolkerstorfer A, Böhm M, Xiang LF, Rush E, Hamzavi IH, Passeron T, Lim H, Harris JE, Parsad D, Huggins R, Schneider A, Kolios A, Rosmarin D, Mohammad TF, Esmat SM, Jones J, Retzer A, Seneschal J, Gkini MA, Ahmed A, Thompson A, Pandya AG, Cruz Rivera S, Kpenou FC, Ezzedine K; INTERCEPT Study Group and the Global Vitiligo Atlas. Eleftheriadou V, et al. JAMA Dermatol. 2026 May 1;162(5):515-524. doi: 10.1001/jamadermatol.2026.0294. JAMA Dermatol. 2026. PMID: 41879771
OBJECTIVE: To develop internationally agreed-upon definitions and criteria for vitiligo severity and relapse as part of the International Consensus on Definition of Severity and Relapse in Vitiligo study. ...Twelve criteria for upgrading severity were recommended, e …
OBJECTIVE: To develop internationally agreed-upon definitions and criteria for vitiligo severity and relapse as part of the Internati …
Vitiligo is not a cosmetic disease.
Ezzedine K, Sheth V, Rodrigues M, Eleftheriadou V, Harris JE, Hamzavi IH, Pandya AG; Vitiligo Working Group. Ezzedine K, et al. Among authors: rodrigues m. J Am Acad Dermatol. 2015 Nov;73(5):883-5. doi: 10.1016/j.jaad.2015.07.039. J Am Acad Dermatol. 2015. PMID: 26475548 No abstract available.
19 results